NCT04473794 Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
| NCT ID | NCT04473794 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins University |
| Condition | Pancreatic Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2022-07-20 |
| Primary Completion | 2035-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2022-07-20 with a primary completion date of 2035-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant, pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.
Eligibility Criteria
Inclusion Criteria: * Adult patients age 18 years and older * Referred for assessment of a pancreatic cyst. Exclusion Criteria: * Medically ill patients with American Society of Anesthesiologists class 4 or greater. * Inability to provide informed consent. * Pregnancy or lactation.
Contact & Investigator
Elham Afghani, MD MPH
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT04473794 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04473794 currently recruiting?
Yes, NCT04473794 is actively recruiting participants. Contact the research team at eafghan1@jhmi.edu for enrollment information.
Where is the NCT04473794 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT04473794 clinical trial?
NCT04473794 is sponsored by Johns Hopkins University. The principal investigator is Elham Afghani, MD MPH at Johns Hopkins University. The trial plans to enroll 5,000 participants.